Mary Richards

A passionate advocate who campaigned for change with METUPUK as a passionate advocate and worked with Secondary First secondary breast cancer charity to raise money and funds for SBC.
She leaves a husband and 3 sons.
We loved Mary who was feisty and not scared to voice her concerns.

Died 30.7.19

Helen Bacon

ER+ DX de novo with extensive liver mets April 2016 Epirubicin & cyclophosphamide Breast surgery & lymph clearance Radiotherapy Paclitaxel Gemcitabine & carboplatin Hysterectomy due to progression to ovaries Capecitabine Microwave ablation to liver Palbociclib & Fulvestrant Eribulin.

Private Treatment.

Died 23.2.20
Beth Roberts
Research & Trials

ER+ PR+ HER2- De novo spread to many bones 3 years of letrozole (the last year addition of ibrance) Surgery to support skeleton - corpectomy and hip replacement and removal of primary in breast Current regime capecitabine for 18 months with addition of tamoxifen in the last 2 months Now have ESR1 mutation so hormone therapy may not work. Clinical Trial Fulvestrant This really concerns me as it reduces my future drug lines. NHS Treatment Progressed on clinical trial and liver failed.

Died 16.6.20

Elaine Figgins

ER+ Primary breast cancer 2012 (clear scans) clinical trial, chemo, full mastectomy, RT. Stayed on Tamoxifen and given 5 years all clear March 2018. July 2018 dx with liver, bone and lung mets . Weekly paclitaxel. Scottish Health Service Treatment.

Died 29.6.20

Carolyn Gammon
Kadcyla which was finally approved in Wales May 20 Herceptin, cape and lapatinib (not accessible 3rd line in England) July 20 - brain mets and leptomenginal (brain lining) with lung progression to lungs and liver and vertebrae. WBRT Died 25.9.20 Welsh Health System Treatment
Spread the message